Species | Target name | Source | Bibliographic reference |
---|---|---|---|
Homo sapiens | ATPase family, AAA domain containing 5 | Starlite/ChEMBL | No references |
Homo sapiens | breast cancer 1, early onset | Starlite/ChEMBL | No references |
Species | Potential target | Known druggable target/s | Ortholog Group |
---|---|---|---|
Echinococcus multilocularis | atpase aaa+ type core atpase aaa type core | Get druggable targets OG5_139225 | All targets in OG5_139225 |
Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Trypanosoma cruzi | BRCA1 C Terminus (BRCT) domain containing protein, putative | 0.0012 | 0 | 0.5 |
Giardia lamblia | Replication factor C, subunit 1 | 0.0012 | 0.00000034704 | 0.5 |
Trichomonas vaginalis | replication factor C large subunit, putative | 0.0012 | 0.00000034704 | 1 |
Loa Loa (eye worm) | hypothetical protein | 0.029 | 0.288 | 1 |
Loa Loa (eye worm) | hypothetical protein | 0.029 | 0.288 | 1 |
Echinococcus granulosus | replication factor c subunit 1 | 0.0012 | 0.00000034704 | 0.000001205 |
Onchocerca volvulus | Peroxidase homolog | 0.029 | 0.288 | 1 |
Wolbachia endosymbiont of Brugia malayi | NAD-dependent DNA ligase, Lig | 0.0012 | 0 | 0.5 |
Loa Loa (eye worm) | hypothetical protein | 0.029 | 0.288 | 1 |
Chlamydia trachomatis | DNA ligase | 0.0012 | 0 | 0.5 |
Brugia malayi | Animal haem peroxidase family protein | 0.029 | 0.288 | 1 |
Trypanosoma cruzi | hypothetical protein, conserved | 0.0012 | 0 | 0.5 |
Loa Loa (eye worm) | hypothetical protein | 0.029 | 0.288 | 1 |
Onchocerca volvulus | Peroxidasin homolog | 0.029 | 0.288 | 1 |
Loa Loa (eye worm) | hypothetical protein | 0.029 | 0.288 | 1 |
Onchocerca volvulus | 0.029 | 0.288 | 1 | |
Loa Loa (eye worm) | hypothetical protein | 0.029 | 0.288 | 1 |
Brugia malayi | Animal haem peroxidase family protein | 0.029 | 0.288 | 1 |
Brugia malayi | Animal haem peroxidase family protein | 0.029 | 0.288 | 1 |
Entamoeba histolytica | Activator 1 140 kDa subunit, putative | 0.0012 | 0.00000034704 | 1 |
Plasmodium falciparum | replication factor C subunit 1, putative | 0.0012 | 0.00000034704 | 0.5 |
Trypanosoma cruzi | hypothetical protein, conserved | 0.0012 | 0 | 0.5 |
Schistosoma mansoni | chromosome transmission fidelity factor | 0.0012 | 0.00000034704 | 0.000001205 |
Onchocerca volvulus | Dual oxidase homolog | 0.029 | 0.288 | 1 |
Loa Loa (eye worm) | hypothetical protein | 0.029 | 0.288 | 1 |
Echinococcus multilocularis | peroxidasin | 0.029 | 0.288 | 0.288 |
Loa Loa (eye worm) | blistered cuticle protein 3 | 0.029 | 0.288 | 1 |
Loa Loa (eye worm) | hypothetical protein | 0.029 | 0.288 | 1 |
Mycobacterium ulcerans | NAD-dependent DNA ligase LigA | 0.0012 | 0 | 0.5 |
Loa Loa (eye worm) | hypothetical protein | 0.029 | 0.288 | 1 |
Loa Loa (eye worm) | hypothetical protein | 0.029 | 0.288 | 1 |
Trichomonas vaginalis | chromosome transmission fidelity factor, putative | 0.0012 | 0.00000034704 | 1 |
Onchocerca volvulus | 0.029 | 0.288 | 1 | |
Brugia malayi | Animal haem peroxidase family protein | 0.029 | 0.288 | 1 |
Schistosoma mansoni | peroxidasin | 0.029 | 0.288 | 1 |
Loa Loa (eye worm) | hypothetical protein | 0.029 | 0.288 | 1 |
Trichomonas vaginalis | chromosome transmission fidelity factor, putative | 0.0012 | 0.00000034704 | 1 |
Brugia malayi | Blistered cuticle protein 3 | 0.029 | 0.288 | 1 |
Brugia malayi | Animal haem peroxidase family protein | 0.029 | 0.288 | 1 |
Brugia malayi | hypothetical protein | 0.029 | 0.288 | 1 |
Loa Loa (eye worm) | animal heme peroxidase | 0.029 | 0.288 | 1 |
Brugia malayi | Peroxidasin | 0.029 | 0.288 | 1 |
Onchocerca volvulus | 0.029 | 0.288 | 1 | |
Trypanosoma cruzi | FHA domain containing protein, putative | 0.0012 | 0 | 0.5 |
Echinococcus multilocularis | replication factor c subunit 1 | 0.0012 | 0.00000034704 | 0.00000034704 |
Loa Loa (eye worm) | animal heme peroxidase | 0.029 | 0.288 | 1 |
Onchocerca volvulus | Peroxidase homolog | 0.029 | 0.288 | 1 |
Toxoplasma gondii | ATPase, AAA family protein | 0.0012 | 0.00000034704 | 1 |
Trypanosoma brucei | BRCA1 C Terminus (BRCT) domain containing protein, putative | 0.0012 | 0 | 0.5 |
Onchocerca volvulus | Chorion peroxidase homolog | 0.029 | 0.288 | 1 |
Schistosoma mansoni | peroxidasin | 0.029 | 0.288 | 1 |
Onchocerca volvulus | Peroxidasin homolog | 0.029 | 0.288 | 1 |
Mycobacterium leprae | PROBABLE DNA LIGASE [NAD DEPENDENT] LIGA (POLYDEOXYRIBONUCLEOTIDE SYNTHASE [NAD+]) | 0.0012 | 0 | 0.5 |
Plasmodium vivax | replication factor C subunit 1, putative | 0.0012 | 0.00000034704 | 0.5 |
Loa Loa (eye worm) | hypothetical protein | 0.029 | 0.288 | 1 |
Loa Loa (eye worm) | hypothetical protein | 0.029 | 0.288 | 1 |
Loa Loa (eye worm) | hypothetical protein | 0.029 | 0.288 | 1 |
Loa Loa (eye worm) | animal heme peroxidase | 0.029 | 0.288 | 1 |
Loa Loa (eye worm) | animal heme peroxidase | 0.029 | 0.288 | 1 |
Echinococcus granulosus | peroxidasin | 0.029 | 0.288 | 1 |
Treponema pallidum | DNA ligase (lig) | 0.0012 | 0 | 0.5 |
Activity type | Activity value | Assay description | Source | Reference |
---|---|---|---|---|
Potency (functional) | 4.6535 uM | PUBCHEM_BIOASSAY: Primary qHTS for delayed death inhibitors of the malarial parasite plastid, 96 hour incubation. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID488745, AID488752, AID488774, AID504848, AID504850] | ChEMBL. | No reference |
Potency (functional) | 11.2202 uM | PubChem BioAssay. qHTS Assay to Identify Small Molecule Activators of BRCA1 Expression. (Class of assay: confirmatory) | ChEMBL. | No reference |
Potency (functional) | 11.6891 uM | PUBCHEM_BIOASSAY: Primary qHTS for delayed death inhibitors of the malarial parasite plastid, 48 hour incubation. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID488752, AID488774, AID504848, AID504850] | ChEMBL. | No reference |
Potency (functional) | 18.3489 uM | PUBCHEM_BIOASSAY: qHTS screen for small molecules that inhibit ELG1-dependent DNA repair in human embryonic kidney (HEK293T) cells expressing luciferase-tagged ELG1. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID493107, AID493125] | ChEMBL. | No reference |
Potency (functional) | 26.8545 uM | PUBCHEM_BIOASSAY: qHTS profiling assay for firefly luciferase inhibitor/activator using purified enzyme and Km concentrations of substrates (counterscreen for miR-21 project). (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2288, AID2289, AID2598, AID411] | ChEMBL. | No reference |
Potency (functional) | = 31.6228 um | PUBCHEM_BIOASSAY: qHTS Assay for Enhancers of SMN2 Splice Variant Expression. (Class of assay: confirmatory) | ChEMBL. | No reference |
Potency (binding) | = 35.4813 um | PUBCHEM_BIOASSAY: qHTS Assay for Identification of Novel General Anesthetics. In this assay, a GABAergic mimetic model system, apoferritin and a profluorescent 1-aminoanthracene ligand (1-AMA), was used to construct a competitive binding assay for identification of novel general anesthetics (Class of assay: confirmatory) [Related pubchem assays: 2385 (Probe Development Summary for Identification of Novel General Anesthetics), 2323 (Validation apoferritin assay run on SigmaAldrich LOPAC1280 collection)] | ChEMBL. | No reference |
Potency (functional) | 35.4813 uM | PUBCHEM_BIOASSAY: qHTS for Inhibitors of binding or entry into cells for Lassa Virus. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID463114, AID540249] | ChEMBL. | No reference |
Potency (functional) | 89.1251 uM | PUBCHEM_BIOASSAY: qHTS for Inhibitors of Polymerase Iota. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID588623] | ChEMBL. | No reference |
Species name | Source | Reference | Is orphan |
---|---|---|---|
Plasmodium falciparum | ChEMBL23 |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.